These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10087958)

  • 21. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 2. 18-22 April 2009, Denver, CO, USA.
    Gale S; McGee V; Lee W
    IDrugs; 2009 Jun; 12(6):335-8. PubMed ID: 19517309
    [No Abstract]   [Full Text] [Related]  

  • 22. Endogenous inhibitors of angiogenesis.
    Folkman J
    Harvey Lect; 1996-1997; 92():65-82. PubMed ID: 15372744
    [No Abstract]   [Full Text] [Related]  

  • 23. Diflomotecan. Ipsen.
    Osheroff N
    IDrugs; 2004 Mar; 7(3):257-63. PubMed ID: 15011101
    [No Abstract]   [Full Text] [Related]  

  • 24. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 1. 18-22 April 2009, Denver, CO, USA.
    Gale S; McGee V; Lee W
    IDrugs; 2009 Jun; 12(6):331-4. PubMed ID: 19517308
    [No Abstract]   [Full Text] [Related]  

  • 25. Resistance to chemotherapy in cancer: a complex and integrated cellular response.
    Mellor HR; Callaghan R
    Pharmacology; 2008; 81(4):275-300. PubMed ID: 18259091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer drugs in pipeline span wide spectrum.
    McCann J
    J Natl Cancer Inst; 2001 Mar; 93(6):424-6. PubMed ID: 11259465
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeting the molecular basis for tumour hypoxia.
    Carroll VA; Ashcroft M
    Expert Rev Mol Med; 2005 Apr; 7(6):1-16. PubMed ID: 15831177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epothilone D (Kosan/Roche).
    Kolman A
    Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inducing indigestion: companies embrace autophagy inhibitors.
    Garber K
    J Natl Cancer Inst; 2011 May; 103(9):708-10. PubMed ID: 21515831
    [No Abstract]   [Full Text] [Related]  

  • 30. A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
    Goss G; Siu LL; Gauthier I; Chen EX; Oza AM; Goel R; Maroun J; Powers J; Walsh W; Maclean M; Drolet DW; Rusk J; Seymour LK;
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):703-10. PubMed ID: 16528532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting mitochondria emerges as therapeutic strategy.
    Garber K
    J Natl Cancer Inst; 2005 Dec; 97(24):1800-1. PubMed ID: 16368937
    [No Abstract]   [Full Text] [Related]  

  • 32. [Resistance to cytostatic drugs].
    Elonen E
    Duodecim; 1998; 114(13):1319-28. PubMed ID: 11552258
    [No Abstract]   [Full Text] [Related]  

  • 33. SOP 13: Pharmacokinetic data analysis.
    Onkologie; 2003 Oct; 26 Suppl 6():56-9. PubMed ID: 23570190
    [No Abstract]   [Full Text] [Related]  

  • 34. AG 3340.
    Drugs R D; 1999 Feb; 1(2):137-8. PubMed ID: 10566007
    [No Abstract]   [Full Text] [Related]  

  • 35. Alkylating agents.
    Connors TA
    Cancer Chemother Biol Response Modif; 1991; 12():27-42. PubMed ID: 1931447
    [No Abstract]   [Full Text] [Related]  

  • 36. TLK-286.
    Verschraegen CF; Smith HO; Lee FC; Cathcart C; Norenberg JP
    IDrugs; 2004 Aug; 7(8):771-81. PubMed ID: 15334311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining carefully selected drug, patient genetics may lead to total tumor death.
    Tuma RS
    J Natl Cancer Inst; 2007 Oct; 99(20):1505-6, 1509. PubMed ID: 17925530
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of angiogenesis in cancer patients.
    Verheul HM; Pinedo HM
    Expert Opin Emerg Drugs; 2005 May; 10(2):403-12. PubMed ID: 15934875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of UCN-01 development: a lesson in the importance of clinical pharmacology.
    Fuse E; Kuwabara T; Sparreboom A; Sausville EA; Figg WD
    J Clin Pharmacol; 2005 Apr; 45(4):394-403. PubMed ID: 15778420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.